CRSP
Price
$45.37
Change
+$0.47 (+1.05%)
Updated
Oct 4 closing price
25 days until earnings call
RXRX
Price
$6.11
Change
+$0.05 (+0.83%)
Updated
Oct 4 closing price
32 days until earnings call
Ad is loading...

CRSP vs RXRX

Header iconCRSP vs RXRX Comparison
Open Charts CRSP vs RXRXBanner chart's image
CRISPR Therapeutics AG
Price$45.37
Change+$0.47 (+1.05%)
Volume$1.13M
CapitalizationN/A
Recursion Pharmaceuticals
Price$6.11
Change+$0.05 (+0.83%)
Volume$3.85M
CapitalizationN/A
View a ticker or compare two or three
CRSP vs RXRX Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CRSP vs. RXRX commentary
Oct 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a StrongSell and RXRX is a Sell.

COMPARISON
Comparison
Oct 06, 2024
Stock price -- (CRSP: $45.37 vs. RXRX: $6.11)
Brand notoriety: CRSP and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 100% vs. RXRX: 73%
Market capitalization -- CRSP: $4B vs. RXRX: $1.97B
CRSP [@Biotechnology] is valued at $4B. RXRX’s [@Biotechnology] market capitalization is $1.97B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, RXRX is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 2 TA indicator(s) are bullish while RXRX’s TA Score has 3 bullish TA indicator(s).

  • CRSP’s TA Score: 2 bullish, 5 bearish.
  • RXRX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than CRSP.

Price Growth

CRSP (@Biotechnology) experienced а -4.12% price change this week, while RXRX (@Biotechnology) price change was -12.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +1.89%, and the average quarterly price growth was -5.77%.

Reported Earning Dates

CRSP is expected to report earnings on Oct 30, 2024.

RXRX is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($4B) has a higher market cap than RXRX($1.97B). CRSP YTD gains are higher at: -27.524 vs. RXRX (-38.032). CRSP (-335.17M) and RXRX (-348.35M) have comparable annual earnings (EBITDA) . CRSP (484M) and RXRX (474M) have equal amount of cash in the bank . RXRX has less debt than CRSP: RXRX (89.9M) vs CRSP (231M). CRSP has higher revenues than RXRX: CRSP (200M) vs RXRX (48.6M).
CRSPRXRXCRSP / RXRX
Capitalization4B1.97B203%
EBITDA-335.17M-348.35M96%
Gain YTD-27.524-38.03272%
P/E RatioN/AN/A-
Revenue200M48.6M412%
Total Cash484M474M102%
Total Debt231M89.9M257%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPRXRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTXFX45.420.71
+1.59%
FullerThaler Behavioral Sm-Cp Gr R6
FRMCX30.330.43
+1.44%
Franklin Mutual Small-Mid Cap Val A
IHSIX22.470.25
+1.13%
Hartford Small Company I
PLFMX28.350.25
+0.89%
Principal Large Cap S&P 500 Index R3
LFLTX13.400.11
+0.83%
Lord Abbett Focused Large Cap Value R5

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been loosely correlated with BEAM. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if RXRX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+0.83%
BEAM - RXRX
61%
Loosely correlated
+2.05%
NTLA - RXRX
59%
Loosely correlated
+1.93%
CRSP - RXRX
57%
Loosely correlated
+1.05%
PRME - RXRX
55%
Loosely correlated
+2.93%
KYMR - RXRX
51%
Loosely correlated
-0.81%
More